Loxosceles rufescens: single-institutional epidemiology, diagnosis and treatment

Submitted: 24 October 2023
Accepted: 22 December 2023
Published: 22 January 2024
Abstract Views: 1154
PDF: 169
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.


Loxosceles rufescens, also known as “violin spider” due to its characteristic appearance, is a medium-sized spider species that can potentially pose a threat to humans. For this study, patients who presented to our hospital’s Poison Control Center between January 1, 2022, and December 31, 2022, and met the following inclusion criteria were included: Suspicion of a violin spider bite, as evaluated by our center. Our protocol involves an initial local treatment, which includes local washing with copious water and disinfection, along with the application of chlorotetracycline hydrochloride. Systemic therapy utilizes Amoxicillin and Clavulanic Acid as the first-line medication. The primary endpoints of this study are the timing and effectiveness of the treatment for cutaneous lesions. Demographic and anamnestic information regarding age, gender, and timelines was summarized using descriptive methods. Our study’s results indicate that erythema and pain are the most frequent symptoms. Loxoscelism is highly concentrated in the Western hemisphere and is considered the only proven arachnological cause of dermo-necrosis. In recent years, there has been an increase in diagnoses.



PlumX Metrics


Download data is not yet available.


Nentwig W, Pantini P, Vetter RS. Distribution and medical aspects of Loxosceles rufescens, one of the most invasive spiders of the world (Araneae: Sicariidae). Toxicon 2017;132:19-28. DOI: https://doi.org/10.1016/j.toxicon.2017.04.007
Nentwig W, Blick T, Gloor D, et al. 2017. Spiders of Europe. Accessed 31 January 2017. Available from: www. araneae.unibe.ch
Rubenstein E, Stoebner PE, Herlin C, et al. Documented cutaneous loxoscelism in the south of France: an unrecognized condition causing delay in diagnosis. Infection 2016;44:383–7. DOI: https://doi.org/10.1007/s15010-015-0869-4
Hubiche T, Delaunay P, del Giudice P. A Case of Loxoscelism in Southern France. Am Soc Tropical Med Hygiene 2013;88:807-8. DOI: https://doi.org/10.4269/ajtmh.12-0339
Shahi M, Shahi A, Khademi Z, et al. Loxoscelism: a case report from Bandar Abbas in south of Iran. Hormozgan Med J 2021;18:421-7.
Köse A, Abacı E, Babus SB, Yazıcı A. Skin necrosis, diffuse urticaria, and cellulitis due to presumed Loxosceles spider bite. Wildern Environ Med 2021;32:198-203. DOI: https://doi.org/10.1016/j.wem.2020.12.005
Trave I, Barabino G, Parodi A. Cutaneous Loxoscelism. JAMA Dermatol 2020;156:203. DOI: https://doi.org/10.1001/jamadermatol.2019.3252
Lopes PH, Squaiella-Baptistão CC, Marques MOT, Tambourgi DV. Clinical aspects, diagnosis and management of Loxosceles spider envenomation: literature and case review. Arch Toxicol 2020;94:1461-77. DOI: https://doi.org/10.1007/s00204-020-02719-0
Nguyen N, Pandey M. Loxoscelism: cutaneous and hematologic manifestations. Adv Hematol 2019;4091278. DOI: https://doi.org/10.1155/2019/4091278
Jerusalem K, Lletí MS. Probable cutaneous loxoscelism with mild systemic symptoms: A case report from Spain. Toxicon 2018;156:7-12. DOI: https://doi.org/10.1016/j.toxicon.2018.10.304
da Silva PH, da Silveira RB, Appel MH, et al. Brown spiders and loxoscelism. Toxicon 2004;44:693-709. DOI: https://doi.org/10.1016/j.toxicon.2004.07.012
Gomez HF, Greenfield DM, Miller MJ, Warren JS. Direct correlation between diffusion of Loxosceles reclusa venom and extent of dermal inflammation. Acad Emerg Med 2001;8:309-14. DOI: https://doi.org/10.1111/j.1553-2712.2001.tb02107.x
Fingermann M, de Roodt AR, Cascone O, Miranda MV. Biotechnological potential of Phospholipase D for Loxosceles antivenom development. Toxicon X 2020;6:100036. DOI: https://doi.org/10.1016/j.toxcx.2020.100036
da Silva MS, Lopes PH, Elias MC, Tambourgi DV. Cytotoxic and genotoxic effects on human keratinocytes triggered by sphingomyelinase D from Loxosceles venom. Arch Toxicol 2020;94:3563-77. DOI: https://doi.org/10.1007/s00204-020-02830-2
Anderson PC. Missouri brown recluse spider: a review and update. Mo Med 1998;95:318-22.
Futrell JM. Loxoscelism. Am J Med Sci 1992;304:261-7. DOI: https://doi.org/10.1097/00000441-199210000-00008
Williams ST, Khare VK, Johnston GA, Blackall DP. Severe intravascular hemolysis associated with brown recluse spider envenomation. A report of two cases and review of the literature. Am J Clin Pathol 1995;104:463-7. DOI: https://doi.org/10.1093/ajcp/104.4.463
Lung JM, Mallory SB. A child with spider bite and glomerulonephritis: a diagnostic challenge. Int J Dermatol 2000;39:287-9. DOI: https://doi.org/10.1046/j.1365-4362.2000.00928.x
Paolino G, Vaira F, Mercuri SR, Di Nicola MR. Fast recogniton of Locsosceles rufescens in Italian spider bites to avoid misdiagnosis, alarmism and start a prompt treatment. J Eur Acad Dermatol Venarol 2020;34:e482-e484. DOI: https://doi.org/10.1111/jdv.16395
Sandoval-Cuevas B, Mervitch-Sigal N, Paz-Michel B, Cabrera-Licona A. Treatment of a Primary Lesion of Cutaneous Loxoscelismo, Complicated by Infection, with Neutral Electrolyzed Water (SES). A Case Report. Revista de la Facultad de Medicina UNAM 2023;66:20-8. DOI: https://doi.org/10.22201/fm.24484865e.2023.66.2.03

How to Cite

Coletta, F., Esposito, S., Di Maiolo, G., Lo Chiatto, F., Cuomo, M., De Marco, G. P., Amitrano, P., Sala, C., Tomasello, A., & Villani, R. (2024). <i>Loxosceles rufescens</i>: single-institutional epidemiology, diagnosis and treatment. Acute Care Medicine Surgery and Anesthesia, 2(1). https://doi.org/10.4081/amsa.2024.38